4d pharma (4d pharma) Net Income (Continuing Operations) : $-73.07 Mil (TTM As of Dec. 2021)

View and export this data going back to 2021. Start your Free Trial

What is 4d pharma Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. 4d pharma's Net Income (Continuing Operations) for the six months ended in Dec. 2021 was $-47.80 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Dec. 2021 was $-73.07 Mil.

4d pharma Net Income (Continuing Operations) Historical Data

The historical data trend for 4d pharma's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4d pharma Net Income (Continuing Operations) Chart

4d pharma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Net Income (Continuing Operations)

Get a 7-Day Free Trial

-27.41

-32.52

-30.32

-34.90

-71.76

4d pharma Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21
Net Income (Continuing Operations)	Get a 7-Day Free Trial											-14.60	-17.18	-16.45	-25.26	-47.80

4d pharma Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Dec. 2021 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-73.07 Mil.

4d pharma (OTCPK:LBPWQ) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

4d pharma Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of 4d pharma's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

4d pharma (4d pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4d pharma PLC (OTCPK:LBPWQ) » Definitions » Net Income (Continuing Operations)

Comparable Companies

Traded in Other Exchanges

N/A

Address

9 Bond Court, Fifth Floor, Leeds, GBR, LS1 2JZ

Website

https://www.4dpharmaplc.com

4d pharma PLC and its subsidiaries are in the business of research and development and production of live biotherapeutic products. The company develops biotherapeutic products for diseases such as cancer, asthma, autism, and autoimmune conditions such as arthritis and multiple sclerosis. Its developing science includes Live biotherapeutics, Microbiome, MicroRx, MicroDx, and others.